CA3042004C - Composes de benzenesulfonamide et leur utilisation en tant qu'agents therapeutiques - Google Patents

Composes de benzenesulfonamide et leur utilisation en tant qu'agents therapeutiques

Info

Publication number
CA3042004C
CA3042004C CA3042004A CA3042004A CA3042004C CA 3042004 C CA3042004 C CA 3042004C CA 3042004 A CA3042004 A CA 3042004A CA 3042004 A CA3042004 A CA 3042004A CA 3042004 C CA3042004 C CA 3042004C
Authority
CA
Canada
Prior art keywords
amino
benzenesulfonamide
difluoro
thiazol
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3042004A
Other languages
English (en)
Other versions
CA3042004A1 (fr
Inventor
Jean-Christophe Andrez
David Earl Bogucki
Kristen Nicole Burford
Sultan Chowdhury
Charles Jay Cohen
Shannon Marie Decker
Christoph Martin Dehnhardt
Robert Joseph Devita
James Roy Empfield
Thilo Focken
Michael Edward GRIMWOOD
Syed Abid Hasan
Qi Jia
Jr. Johnson James Philip
Michael Scott Wilson
Alla Yurevna Zenova
Original Assignee
Xenon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenon Pharmaceuticals Inc filed Critical Xenon Pharmaceuticals Inc
Priority claimed from PCT/US2017/033666 external-priority patent/WO2018106284A1/fr
Publication of CA3042004A1 publication Critical patent/CA3042004A1/fr
Application granted granted Critical
Publication of CA3042004C publication Critical patent/CA3042004C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des composés benzènesulfonamides, tels que des stéréoisomères, des énantiomères, des tautomères de ceux-ci ou leurs mélanges, ou leurs sels, solvates ou promédicaments pharmaceutiquement acceptables, pour traiter des maladies ou des affections associées aux canaux sodiques sensibles à la tension, telles que l'épilepsie.
CA3042004A 2016-12-09 2017-05-19 Composes de benzenesulfonamide et leur utilisation en tant qu'agents therapeutiques Active CA3042004C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662432169P 2016-12-09 2016-12-09
US62/432,169 2016-12-09
PCT/US2017/033666 WO2018106284A1 (fr) 2016-12-09 2017-05-19 Composés de benzènesulfonamide et leur utilisation en tant qu'agents thérapeutiques

Publications (2)

Publication Number Publication Date
CA3042004A1 CA3042004A1 (fr) 2018-06-14
CA3042004C true CA3042004C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
McKeithan et al. Reengineering an antiarrhythmic drug using patient hiPSC cardiomyocytes to improve therapeutic potential and reduce toxicity
Zhu et al. Cortical neurons lacking KCC2 expression show impaired regulation of intracellular chloride
Ziemann et al. Seizure termination by acidosis depends on ASIC1a
JP6556154B2 (ja) イソキノリン誘導体及びその使用
Khosravani et al. Voltage-gated calcium channels and idiopathic generalized epilepsies
EP3097078B1 (fr) Pyridines et pyrimidines, et leur utilisation
CA2934473C (fr) Indazoles et leur utilisation
Hefter et al. Amyloid precursor protein protects neuronal network function after hypoxia via control of voltage-gated calcium channels
Miceli et al. Pharmacological targeting of neuronal Kv7. 2/3 channels: a focus on chemotypes and receptor sites
JP2019031531A (ja) アザスピロ[4.5]デカン誘導体及びその使用
JP6186494B2 (ja) カルボキサミド誘導体及びその使用
RS66796B1 (sr) Jedinjenja benzensulfonamida i njihova primena kao terapeutski agensi
Jhamandas et al. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease
EP1968956A2 (fr) Antagonistes des canaux calciques
Diszházi et al. TRPM4 links calcium signaling to membrane potential in pancreatic acinar cells
Sidell et al. Menthol blocks dihydropyridine‐insensitive Ca2+ channels and induces neurite outgrowth in human neuroblastoma cells
Romito et al. A comprehensive protocol for efficient differentiation of human NPCs into electrically competent neurons
Halterman et al. Loss of c/EBP-β activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons
Huan et al. Activation of melatonin receptor increases a delayed rectifier K+ current in rat cerebellar granule cells
Yacoub et al. Neuronal growth patterns and synapse formation are mediated by distinct activity-dependent mechanisms
Luk et al. Trophic factor-induced activity ‘signature’regulates the functional expression of postsynaptic excitatory acetylcholine receptors required for synaptogenesis
Miziak et al. Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy
Lopez et al. Structure-function relationship of new peptides activating human Nav1. 1
Stewart et al. KvS regulatory subunits confer drug resistance to Kv2 channels
Wang et al. Long-term effect of early discharge on sEPSC and [Ca2+] i in developing neurons